BG27380A3 - Method of obtaining of erythromycilamine derivaties - Google Patents

Method of obtaining of erythromycilamine derivaties

Info

Publication number
BG27380A3
BG27380A3 BG032727A BG3272776A BG27380A3 BG 27380 A3 BG27380 A3 BG 27380A3 BG 032727 A BG032727 A BG 032727A BG 3272776 A BG3272776 A BG 3272776A BG 27380 A3 BG27380 A3 BG 27380A3
Authority
BG
Bulgaria
Prior art keywords
erythromycilamine
derivaties
obtaining
erythromycilamine derivaties
Prior art date
Application number
BG032727A
Other languages
Bulgarian (bg)
English (en)
Inventor
Roland Maier
Eberhard Woitun
Bernd Wetzel
Wolfgang Reuter
Hanns Goeth
Uwe Lechner
Original Assignee
Неизвестен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25768725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG27380(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2515075A external-priority patent/DE2515075C2/de
Priority claimed from DE19762606030 external-priority patent/DE2606030A1/de
Application filed by Неизвестен filed Critical Неизвестен
Publication of BG27380A3 publication Critical patent/BG27380A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG032727A 1975-04-07 1976-03-29 Method of obtaining of erythromycilamine derivaties BG27380A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2515075A DE2515075C2 (de) 1975-04-07 1975-04-07 Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19762606030 DE2606030A1 (de) 1976-02-14 1976-02-14 Neue erythromycinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
BG27380A3 true BG27380A3 (en) 1979-10-12

Family

ID=25768725

Family Applications (1)

Application Number Title Priority Date Filing Date
BG032727A BG27380A3 (en) 1975-04-07 1976-03-29 Method of obtaining of erythromycilamine derivaties

Country Status (29)

Country Link
US (1) US4048306A (fi)
JP (1) JPS51128991A (fi)
AT (1) AT342770B (fi)
AU (1) AU498418B2 (fi)
BG (1) BG27380A3 (fi)
CA (1) CA1060005A (fi)
CH (2) CH621800A5 (fi)
CS (1) CS196304B2 (fi)
DD (1) DD125218A5 (fi)
DK (1) DK138656C (fi)
ES (2) ES446737A1 (fi)
FI (1) FI63244C (fi)
FR (1) FR2306703A1 (fi)
GB (1) GB1520963A (fi)
GR (1) GR60374B (fi)
HU (1) HU175186B (fi)
IE (1) IE43598B1 (fi)
IL (1) IL49359A (fi)
LU (2) LU88563I2 (fi)
MX (1) MX3277E (fi)
NL (1) NL180107C (fi)
NO (1) NO141411C (fi)
NZ (1) NZ180529A (fi)
PL (1) PL101880B1 (fi)
PT (1) PT64977B (fi)
RO (1) RO68441B (fi)
SE (1) SE425566B (fi)
SU (1) SU682134A3 (fi)
YU (1) YU87676A (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0201166B1 (en) 1985-03-12 1990-02-07 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
US5110800A (en) * 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
US4945080A (en) * 1987-05-26 1990-07-31 Eli Lilly And Company Dirithromycin metabolite
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
DE69127457T2 (de) * 1990-11-28 1998-01-22 Taisho Pharmaceutical Co., Ltd., Tokio/Tokyo 6-0-methylerythromycin a-derivat
ZA922777B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical formulation containing dirithromycin
US5556839A (en) * 1991-04-29 1996-09-17 Eli Lilly And Company Form II Dirithromycin
ZA927328B (en) * 1991-09-30 1994-03-24 Lilly Co Eli One step process for production of dirithromycin
DE4410637C1 (de) * 1994-03-26 1995-09-21 Boehringer Ingelheim Vetmed Injizierbare Lösungen von Dirithromycin
AU9645998A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US6436906B1 (en) 2001-04-02 2002-08-20 Enanta Pharmaceuticals, Inc. 9-amino-14-membered macrolides derived from leucomycins
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1648418A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2535177A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
US8460710B2 (en) 2003-09-15 2013-06-11 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2572292A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660376A (en) * 1970-09-30 1972-05-02 Lilly Co Eli N-arylidene erythromycylamines

Also Published As

Publication number Publication date
NL180107C (nl) 1987-01-02
ES446737A1 (es) 1977-10-16
SE425566B (sv) 1982-10-11
FI63244C (fi) 1983-05-10
NL180107B (nl) 1986-08-01
JPS62158B2 (fi) 1987-01-06
CS196304B2 (en) 1980-03-31
SE7604052L (sv) 1976-10-08
PL101880B1 (pl) 1979-02-28
YU87676A (en) 1982-08-31
AU1272276A (en) 1977-10-13
DK138656B (da) 1978-10-09
CA1060005A (en) 1979-08-07
FR2306703A1 (fr) 1976-11-05
FI760845A (fi) 1976-10-08
HU175186B (hu) 1980-05-28
DK145276A (da) 1976-10-08
NO761172L (fi) 1976-10-08
IL49359A (en) 1979-07-25
NZ180529A (en) 1978-09-20
US4048306A (en) 1977-09-13
LU74702A1 (fi) 1977-06-03
RO68441B (ro) 1983-04-30
GR60374B (en) 1978-05-23
IE43598B1 (en) 1981-04-08
ATA149976A (de) 1977-08-15
IE43598L (en) 1976-10-07
SU682134A3 (ru) 1979-08-25
MX3277E (es) 1980-08-15
PT64977B (de) 1978-04-03
RO68441A (ro) 1983-04-29
NL7603569A (nl) 1976-10-11
GB1520963A (en) 1978-08-09
AT342770B (de) 1978-04-25
FI63244B (fi) 1983-01-31
DD125218A5 (de) 1977-04-06
ES456567A1 (es) 1978-03-01
LU88563I2 (fr) 1995-03-21
IL49359A0 (en) 1976-06-30
NO141411C (no) 1980-03-05
JPS51128991A (en) 1976-11-10
FR2306703B1 (fi) 1979-10-12
PT64977A (de) 1976-05-01
CH624413A5 (fi) 1981-07-31
DK138656C (da) 1979-04-02
NO141411B (no) 1979-11-26
CH621800A5 (fi) 1981-02-27
AU498418B2 (en) 1979-03-15

Similar Documents

Publication Publication Date Title
BG27553A3 (en) Method of obtaining of 2- phenyl- 3- aroylxenzothiophenes
BG27380A3 (en) Method of obtaining of erythromycilamine derivaties
BG24673A3 (en) Method of obtaining quinazone derivatives
BG27362A3 (en) Method of obtaining n- phenyl- n- benzoyl carbamides
BG27548A3 (en) Method of obtaining of carbonylsubstituated 1- sulphanylbenzimidazoles
BG27554A3 (en) Method of obtaining of derivatives of 2- aroyl- 3- phenyl- bewzothiophenes
BG24799A3 (en) Method of obtaining benzoylureidediphenyl-esters
BG27355A3 (en) Method of obtaining of 11- desoxy- 16- ariloxy- w- tetranoprostaglandines
JPS5280987A (en) Method of forming can
BG27543A3 (en) Method of obtaining of n- aryl- n- (1- l- 4- piperidinyj)- arylacetamides
BG24801A3 (en) Method of obtaining l-pyroglutamyl-l-prolineamide
JPS5280397A (en) Popymerization method of epsilonncaprolactam
JPS51146407A (en) Method of producing 22aminoonnbutanol
BG27732A3 (en) Method of obtaining of di- substituated phenolethers of 3- amino- 2-hydroxipropane
JPS5253807A (en) Method of producing 22aminoo11alcohol
JPS51138618A (en) Method of producing iminodiacetonitlile
BG27555A3 (en) Method of obtaining of derivatives of aroyl- phenilnaphtalenes
JPS5250560A (en) Method of forming throughhhole
BG27373A3 (en) Method of obtaining of gamapyrones
JPS51145588A (en) Method of continuous phtoopolymerization
JPS5224962A (en) Method of colddrolling
JPS5236616A (en) Method of producing 22chloroalkanal
BG24228A3 (en) Method of preparing n-alkenyl-2-aminomethylpyrrolidine
JPS523849A (en) Method of making sugarrpreserved kumguat
JPS5247961A (en) Isorating method of steviocide